A Study to Assess the Safety and Efficacy of LB1410 in Participants With Advanced Solid Tumor or Lymphoma(Keyplus-001)
NCT05357651
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Lymphoma
Interventions
DRUG:
LB1410
Sponsor
L & L Bio Co., Ltd., Ningbo, China